Connor Dowling is the executive director of Offit Capital, which invests in innovative research, patient support, and clinical initiatives that bring hope to individuals and families facing glioblastoma. He previously served as CEO of GenoTwin, where he dedicated his career to the exciting intersection of life sciences and entrepreneurship. With five years of experience at Weill Cornell Medicine, he helped establish and run the BioVenture Entrepreneurship division, focusing on the commercialization of early-stage intellectual property. Passionate about the intersection of business and international issues, Connor pursued a master’s in global business administration from the Fletcher School at Tufts University.